Antibiotic resistance: challenges and successes in respiratory infection.

about

Antibiotic resistance: challenges and successes in respiratory infection.

Item

http://www.wikidata.org/entity/Q44268356

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Antibiotic resistance: challenges and successes in respiratory infection.

@en

Antibiotic resistance: challenges and successes in respiratory infection.

@nl

type

Item

label

Antibiotic resistance: challenges and successes in respiratory infection.

@en

Antibiotic resistance: challenges and successes in respiratory infection.

@nl

prefLabel

Antibiotic resistance: challenges and successes in respiratory infection.

@en

Antibiotic resistance: challenges and successes in respiratory infection.

@nl

P1476

Antibiotic resistance: challenges and successes in respiratory infection.

@en

P2093

Jenny Bryan

http://www.w3.org/2001/XMLSchema#string

Sanjay Sethi

http://www.w3.org/2001/XMLSchema#string

P2860

Aerosolized Antibiotics

Q&A: Antibiotic resistance: where does it come from and what can we do about it?

Efficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumonia

A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation.

Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance.

Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens.

Structural and molecular basis for resistance to aminoglycoside antibiotics by the adenylyltransferase ANT(2″)-Ia

An unusual class of anthracyclines potentiate Gram-positive antibiotics in intrinsically resistant Gram-negative bacteria.

Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia.

Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections.

P304

481-484

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FMB-2016-0006

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27081910

http://www.w3.org/2001/XMLSchema#string